Mid-Day Market Update 11 July 2025: Nifty Below 25,160 as IT Drags, HUL and Glenmark Buck the Trend
By CapitalKeeper | Mid Day | Indian Equities | Market Moves That Matter
Indian stock market mid-day update for July 11, 2025: Nifty drops to 25,159 as TCS-led IT slide continues. Bank Nifty, Sensex, and Fin Nifty remain under pressure. HUL surges on new CEO news, Glenmark Pharma rallies on global licensing deal.
📊 Index Update (Mid‑Day July 11)
- Nifty 50: Opened 25,255.50, now 25,159.45 (−96.05 pts; −0.38%)
- Bank Nifty: From 56,843.45 to 56,719.65 (−123.80 pts; −0.22%)
- Sensex: From 82,820.76 to 82,528.90 (−291.86 pts; −0.35%)
- Fin Nifty: From 26,917.50 to 26,853.50 (−64.00 pts; −0.24%)
The session is reflecting profit-taking pressure following IT weakness, with Nifty struggling below 25,200–25,300. Reuters notes an IT-led slide after TCS reported soft Q1 revenues, while tariff tensions and rupee depreciation are weighing on sentiment.

🔍 Sector Snapshot & Movers
🧑💻 IT
- The biggest laggard: Nifty IT down 1.1%. Major players TCS, Infosys, and Wipro dropped 2%, 1.5%, and 1.2% respectively, after TCS’ Q1 revenue fell short of estimates.
🛒 FMCG

- The only bright spot: Hindustan Unilever surged 4.4% following the appointment of new CEO Priya Nair, lifting the FMCG index.
🪙 Pharma
- Glenmark Pharma jumped 10% after securing a licensing deal with AbbVie on cancer drugs.
🛢️ Auto & Metals
- Autos continue to underperform: Nifty Auto index declined 1.3% .
- Metals also flat/weak, amid broader risk-off sentiment.
🏗️ Banking & Financials
- Hold-ups across Bank Nifty and Fin Nifty indexes; volumes pulled back after derivatives volatility dropped.
📈 Technical Outlook
- Nifty dropped below key support zone of 25,200–25,300, now aiming for 25,100. A sustained break below 25,150 may prompt a test of 25,000.
- Bank Nifty remains range-bound between 56,600–57,000. A bounce above ~57k could stabilize financials.
- Fin Nifty mirrors banking; banks showing mixed trend, though some housing/power financiers are holding up.
🌍 Global & Macro Factors
- TCS revenue miss: A signal of cautious global IT spending amid U.S. trade tariff worries.
- Global trade pressure: Trump’s 35% tariff on Canada, and 15–20% possible on other partners, is dampening risk appetite.
- Rupee weakness: The INR weakened 0.3% to 85.8650/USD, pressured by dollar strength and modest FII outflows.
- Options volume drop: SEBI’s ban on Jane Street continues to suppress Bank Nifty derivative volumes.
- Asian outlook: Mixed performance, with inflows into Asia’s shares in June, though tariff jitters remain top-of-mind.
🔔 Intraday Watchlist
- TCS & Tech space: Any further headwinds from earnings could drag broader markets.
- HUL & Select Pharma: Tactical rallies likely driven by corporate news.
- Support Level: Nifty 25,100–25,150 watch for bounce or break.
- Rupee Reaction: A test of 86/USD likely to pressure importers, pharma, and capped consumer names.
✅ Mid‑Day Summary
Markets are under pressure, led by IT-related selloffs and macro uncertainty. Defensive plays like FMCG and pharma are outperforming, while banking and auto sectors are struggling. Technically, Nifty is flirting with 25,150 support; clarity may come from trade headlines and Q1 tech earnings. Remain cautious, with pivot levels guiding day’s flow.
📌 For more real-time updates, trade setups, and investment insights — follow us on [Telegram] and [WhatsApp Channel] subscribe to our newsletter!

📌 Disclaimer
The content provided on CapitalKeeper.in is for informational and educational purposes only and does not constitute investment, trading, or financial advice. While we strive to present accurate and up-to-date market data and analysis, we make no warranties or representations regarding the completeness, reliability, or accuracy of the information.
Stock market investments are subject to market risks, and readers/investors are advised to conduct their own due diligence or consult a SEBI-registered financial advisor before making any investment decisions. CapitalKeeper and its authors are not liable for any loss or damage, direct or indirect, arising from the use of this information.
All views and opinions expressed are personal and do not reflect the official policy or position of any agency or organization. Past performance is not indicative of future results.
By using this website, you agree to the terms of this disclaimer.
Leave a Reply